Shanghai Bao Pharmaceuticals Co., Ltd. | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract disorder, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, head and neck squamous cell carcinoma, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, squamous cell carcinoma	Not yet recruiting	Phase 1	2025-06-25		NCT07036185
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns	burn, injury	Recruiting	Phase 2	2025-06-17		NCT07025408
A Clinical Trial With KJ103 in Anti-GBM Disease	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, anti-glomerular basement membrane disease, autoimmune disease, glomerulonephritis, immune system disorder, interstitial lung disease, kidney disorder, lung disorder, nephritis, respiratory system disorder, urinary system disorder	Active, not recruiting	Phase 2	2025-06-13		NCT06607016